Adjuvants and Vector Systems for Allergy Vaccines
- 1 May 2011
- journal article
- review article
- Published by Elsevier in Immunology and Allergy Clinics of North America
- Vol. 31 (2) , 407-419
- https://doi.org/10.1016/j.iac.2011.03.001
Abstract
No abstract availableKeywords
This publication has 96 references indexed in Scilit:
- Modular antigen-translocation as a novel vaccine strategy for allergen-specific immunotherapyCurrent Opinion in Allergy and Clinical Immunology, 2009
- Displaying Fel d1 on virus-like particles prevents reactogenicity despite greatly enhanced immunogenicity: a novel therapy for cat allergyThe Journal of Experimental Medicine, 2009
- Natural Self-Assembly of Allergen-S-Layer Fusion Proteins Is No Prerequisite for Reduced Allergenicity and T Cell Stimulatory CapacityInternational Archives of Allergy and Immunology, 2009
- IL-10-Inducing Adjuvants Enhance Sublingual Immunotherapy Efficacy in a Murine Asthma ModelInternational Archives of Allergy and Immunology, 2007
- Translational Mini-Review Series on Toll-like Receptors:
Toll-like receptor ligands as novel pharmaceuticals for allergic disordersClinical and Experimental Immunology, 2007
- Induction of interleukin 10 by sublingual immunotherapy for house dust mites: a preliminary reportAnnals of Allergy, Asthma & Immunology, 2005
- The effect of BCG vaccine at birth on the development of atopy or allergic disease in young childrenAnnals of Allergy, Asthma & Immunology, 2004
- Effect of Mycobacterium vaccae on atopic dermatitis in children of different agesBritish Journal of Dermatology, 2003
- IL‐10 and TGF‐β cooperate in the regulatory T cell response to mucosal allergens in normal immunity and specific immunotherapyEuropean Journal of Immunology, 2003
- Safety and efficacy studies of liposomes in specific immunotherapyCurrent Therapeutic Research, 1999